Nedra Johnson

Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy

H. Rui, A. Banerjee, S. Tsaih, 2023, Research square.

Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy.

H. Rui, A. Banerjee, S. Tsaih, 2023, Breast Cancer Research and Treatment.